---
name: JNJ trades
last_updated: 2026-04-30
last_run_id: 20260430_194522
target_words: 800
stale_after_days: 60
word_count: 798
summary: First live trade placed — short 4 shares at $229.50 (entered Apr 30, 2026); prior two consecutive holds now historical; short thesis is bearish squeeze resolution in confirmed downtrend
---

# JNJ — Trades

## TL;DR

JNJ now has its first active trade: a short of ~4 shares entered at $229.50 on April 30, 2026, targeting $216.53 with a stop at $235. The trade is the result of the squeeze that was "building" across two prior hold runs finally resolving to the downside. Prior holds (Apr 11 and Apr 15) were correctly cautious — both would have been losers or flat. Confidence is 42%, just above the 40 threshold, with a 2.36:1 R/R. Risk manager allowed a $1,092.87 limit; actual notional is $918 (~4 shares × $229.50). (Source: decisions.json, risk_management_agent signal, run 20260430_194522.)

## Open positions

### Trade — Short (active)

| field | value |
|---|---|
| Status | open |
| Direction | short |
| Quantity | ~4 shares |
| Entry price | $229.50 |
| Target price | $216.53 |
| Stop loss | $235.00 |
| Risk/reward | 2.36:1 |
| Confidence | 42% |
| Timeframe | 5–10 trading days |
| Run ID | 20260430_194522 |
| Mode | swing |
| Entry date | 2026-04-30 |
| Notional | $918 |
| Risk per share | $5.50 (entry $229.50 to stop $235.00) |
| Reward per share | $12.97 (entry $229.50 to target $216.53) |

**Trade thesis.** The Apr 15 Bollinger squeeze resolved bearish — the prior $233 bearish trigger was surpassed and price fell to $227.35. ADX moved from 23 (below threshold, no trend) to 29.46 (trend confirmed) with -DI 33.25 >> +DI 15.99. Daily EMAs are fully aligned downtrend. The hourly bounce into 10-EMA resistance ($229–231) is the entry zone. Macro context is a direct headwind: risk-on regime with S&P at ATH drives capital rotation out of defensive healthcare. No catalyst within 10 days to reverse the trend. (Source: swing_head_trader signal, decisions.json, run 20260430_194522.)

**Primary risk.** Daily RSI at 28.35 (oversold territory) — a snap-back bounce extending above $235 would stop the trade out. Talc litigation is an unscheduled binary wildcard. Mean-reversion agent (52% confidence) sees a bounce to $234–235 as possible. (Source: swing_mean_reversion signal; explanation.json, run 20260430_194522.)

## Closed — last 30 days

None.

## Run history — holds (no trade executed)

### Run: swing_20260411_211655 — April 11, 2026

**Decision**: Hold. Confidence 35%. (Source: decisions.json, run swing_20260411_211655.)

**What the system saw**: Stock at ~$241.30. ADX 22.9 (below 25), RSI 56.9, BB width 0.048 (tight squeeze forming), z-score -0.36 near statistical mean. Earnings binary April 14 was 3 days away — blocked entry. 7/9 agents neutral. Head trader: "Dead zone. Earnings Monday could gap either way." Proposed entry $238.46, target $245, stop $234, R/R 1.5:1 — failed 2:1 minimum. (Source: swing_head_trader.json, run swing_20260411_211655.)

**Lesson**: Hold was correct. Q1 earnings beat but stock barely moved; sellers absorbed the gap-up. A Fibonacci entry at $237–238 would have gained almost nothing near $240. The 1.5:1 R/R filter correctly blocked the trade.

---

### Run: 20260415_110848 — April 15, 2026

**Decision**: Hold. Confidence 42%. (Source: decisions.json, run 20260415_110848.)

**What the system saw**: Stock at ~$237–240. ADX 23 (below 25 threshold), EMAs flat (EMA10 $240.08, EMA21 $240.21), squeeze still ON, daily SuperTrend bearish. 8/9 agents neutral. Head trader: "No position. Monitor for the daily squeeze to release. A decisive close above $244 with volume would trigger a bullish entry." Risk manager allowed $1,375 limit. Trigger levels set: long above $244 on 1.5x volume; short below $233. (Source: decisions.json, run 20260415_110848.)

**What happened**: The $244 bullish trigger was never reached. Price declined further, eventually breaking the $233 bearish trigger, which led to the short setup in this run.

---

## Closed — older than 30 days

None.

## Lifetime stats

| Metric | Value |
|---|---|
| Total trades (order placed) | 1 |
| Open trades | 1 (short ~4 shares at $229.50) |
| Closed trades | 0 |
| Win rate | N/A (no closed trades) |
| Average R:R | 2.36:1 (1 data point) |
| Total realized P&L | $0.00 |
| Total unrealized P&L | open (depends on fill) |
| Runs analyzed | 3 |
| Runs resulting in hold | 2 (Apr 11, Apr 15) |
| Runs resulting in short | 1 (Apr 30) |
| Consecutive holds | 2 (broken by short on Apr 30) |
| Max capital at risk | $918 notional (~4 shares × $229.50) |

## Notes and lessons

**Two holds, then a short — patience paid off.** Both prior holds were correct: the Apr 11 earnings-proximity block saved capital on a muted earnings reaction, and the Apr 15 squeeze-wait call correctly identified direction was unresolved. The bearish resolution on Apr 30 provides the clean entry the system was waiting for.

**RSI oversold is a key risk to manage.** Daily RSI at 28.35 is an early warning that the stock has already fallen far. The system's discipline of entering on the bounce (at 10-EMA resistance ~$229–231) rather than at the flush lows ($227.35) improves the R/R and reduces the risk of being short right at a mean-reversion inflection. Monitor RSI closely — if it bases above 30 with volume pickup, the short thesis may need re-evaluation sooner than the 5–10 day window.
